Unleashing the Power of Exosomes for Early Disease Detection
In today’s symptom-driven healthcare system, early stage disease can be difficult to diagnose as symptoms often do not appear until the disease has progressed, limiting treatment options. Additionally, there is a lack of effective diagnostic tools that can identify diseases in their nascent stages.
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
